ASX - By Stock
|
IBX |
Re:
Ann: Imagion to complete the MagSense HER2 Phase 1 Study
|
|
themack
|
43 |
16K |
0 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
43
|
16K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Results of Meeting
|
|
themack
|
5 |
2.1K |
6 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
5
|
2.1K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems April 2023 Investor Newsletter
|
|
themack
|
19 |
8.2K |
1 |
13/04/23 |
13/04/23 |
ASX - By Stock
|
19
|
8.2K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: 2022 Annual Report to Shareholders
|
|
themack
|
17 |
5.6K |
5 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
17
|
5.6K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Investor Webinar Participation
|
|
themack
|
15 |
5.2K |
6 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
15
|
5.2K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
themack
|
186 |
54K |
2 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
186
|
54K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Company Update - Phase 1 Study Independent Review
|
|
themack
|
186 |
54K |
6 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
186
|
54K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
52 |
17K |
6 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
52
|
17K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
62
|
20K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
62
|
20K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
[VIDEO] Imagion Biosystems (ASX:IBX) human trial results "de-risk" the company's tech
|
|
themack
|
34 |
13K |
5 |
19/01/23 |
19/01/23 |
ASX - By Stock
|
34
|
13K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Abysmal shareholder communication
|
|
themack
|
78 |
28K |
4 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
78
|
28K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
1 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
62
|
20K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
4 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
62
|
20K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
3 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
62
|
20K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
0 |
07/01/23 |
07/01/23 |
ASX - By Stock
|
62
|
20K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
BOB NEEDS TO GO!
|
|
themack
|
62 |
20K |
4 |
30/12/22 |
30/12/22 |
ASX - By Stock
|
62
|
20K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
short term pain long term gain
|
|
themack
|
3 |
1.7K |
0 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
3
|
1.7K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
[VIDEO] Imagion Biosystems (ASX:IBX) human trial results "de-risk" the company's tech
|
|
themack
|
34 |
13K |
4 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
34
|
13K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Positive clinical data reported at breast cancer symposium
|
|
themack
|
110 |
35K |
1 |
08/12/22 |
08/12/22 |
ASX - By Stock
|
110
|
35K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human Study Progress Update
|
|
themack
|
195 |
78K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
195
|
78K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
Imagion Biosystems (ASX:IBX): Big things come in nano packages
|
|
themack
|
141 |
51K |
7 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
141
|
51K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Imagion Biosystems (ASX:IBX): Big things come in nano packages
|
|
themack
|
141 |
51K |
6 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
141
|
51K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Half-Year Investor Presentation
|
|
themack
|
64 |
23K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
64
|
23K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
31 |
9.0K |
2 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
31
|
9.0K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Change of Director's Interest Notice
|
|
themack
|
62 |
19K |
5 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
62
|
19K
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
77 |
24K |
3 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
77
|
24K
|
3
|
|
ASX - By Stock
|
IBX |
Re:
T20 IBX
|
|
themack
|
62 |
23K |
2 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
62
|
23K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: AGM presentation
|
|
themack
|
35 |
15K |
6 |
15/06/22 |
15/06/22 |
ASX - By Stock
|
35
|
15K
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
38 |
16K |
12 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
38
|
16K
|
12
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
themack
|
155 |
59K |
1 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
155
|
59K
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Feedback for IBX management
|
|
themack
|
5 |
2.5K |
4 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
5
|
2.5K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: 2021 Annual Report to Shareholders
|
|
themack
|
163 |
58K |
4 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
163
|
58K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
4th site open
|
|
themack
|
20 |
8.9K |
6 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
20
|
8.9K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: FDA Breakthrough Device Application Update
|
|
themack
|
53 |
15K |
2 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
53
|
15K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
122 |
28K |
0 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
122
|
28K
|
0
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
themack
|
39 |
9.7K |
6 |
30/07/21 |
30/07/21 |
ASX - By Stock
|
39
|
9.7K
|
6
|
|
Charts
|
EMV |
Re:
Chart
|
|
themack
|
2.7K |
1.5M |
5 |
15/07/21 |
15/07/21 |
Charts
|
2.7K
|
1.5M
|
5
|
|
ASX - By Stock
|
IBX |
Re:
Ann: First-in-human study update - First patient enrolled
|
|
themack
|
529 |
180K |
0 |
06/07/21 |
06/07/21 |
ASX - By Stock
|
529
|
180K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
IBX videos
|
|
themack
|
155 |
59K |
14 |
10/06/21 |
10/06/21 |
ASX - By Stock
|
155
|
59K
|
14
|
|
Charts
|
EMV |
Re:
Chart
|
|
themack
|
2.7K |
1.5M |
6 |
31/05/21 |
31/05/21 |
Charts
|
2.7K
|
1.5M
|
6
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
themack
|
5.5K |
1.9M |
1 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
1
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
themack
|
5.5K |
1.9M |
3 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
3
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C - quarterly
|
|
themack
|
224 |
72K |
9 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
224
|
72K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C - quarterly
|
|
themack
|
224 |
72K |
4 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
224
|
72K
|
4
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Appendix 4C - quarterly
|
|
themack
|
224 |
72K |
2 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
224
|
72K
|
2
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Breakthroughs in Technology & Product Development
|
|
themack
|
19 |
6.9K |
9 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
19
|
6.9K
|
9
|
|
ASX - By Stock
|
IBX |
Re:
Interesting
|
|
themack
|
5.5K |
1.9M |
4 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
5.5K
|
1.9M
|
4
|
|
ASX - By Stock
|
AXP |
Re:
Ann: MHP production now exceeding 2,040 BOE per day
|
|
themack
|
497 |
105K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
497
|
105K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Ann: Imagion Biosystems March 2021 Investor Newsletter
|
|
themack
|
98 |
40K |
4 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
98
|
40K
|
4
|
|